Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -45.823% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) Br.CCc1nnc2n1N=C(c1cccc([N+](=O)[O-])c1)CS2
b.) COc1ccc(NC(=O)CCc2ccc(OC)c(OC)c2)cn1
c.) Cc1nc(N2CCN(S(=O)(=O)c3cccc4nonc34)CC2)c2c3c(sc2n1)CCCC3
d.) O=c1cc([O-])n(C2CCCCCC2)c(=O)[nH]1.[NH4+]
e.) CCN1CCN(C(=O)c2ccccc2Nc2ccc(SC(F)F)cc2)CC1.Cl
Answer: e. CCN1CCN(C(=O)c2ccccc2Nc2ccc(SC(F)F)cc2)CC1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(C(=O)c2ccccc2Nc2ccc(SC(F)F)cc2)CC1.Cl
CCN1CCN(C(=O)c2ccccc2Nc2ccc(SC(F)F)cc2)CC1.Cl
[2-[4-(difluoromethylsulfanyl)anilino]phenyl]-(4-ethylpiperazin-1-yl)methanone;hydrochloride